Over the last few months, many Biotechs have been reporting financial difficulties, including several prominent US firms, one of which filed for Chapter 11 protection, commonly known as filing for bankruptcy, on the 14th May amid a storm of publicity.
This has raised concerns about the future of many Biotech companies worldwide, with both investors and loyal customers becoming nervous about long standing companies.
However it isn’t all bad news for Biotech companies, a privately owned UK biotech called Nanogen, specialising in hair loss treatments and hair camouflage products, have reported significant growth in the last 2 quarters compared to last year, and by all reports are weathering the recession well.
Related Articles
Tags: Hair Loss